Current liabilities increased 20.2%
Current liabilities changed +20.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.1B→$3.7B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SNOW financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables increased 11.1%
Trade receivables changed +11.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$646.7M→$718.5M4 prior comparisons
Cash & equivalents decreased 9.2%
Cash & equivalents changed -9.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.9B→$1.7B2 prior comparisons
Capital expenditure decreased 54.7%
Capital expenditure changed -54.7% from the comparable as-filed period.
$16.7M→$7.6M3 prior comparisons
R&D / revenue moved 628 bp lower
R&D / revenue changed -628 basis points from the comparable as-filed period.
42.97%→36.69%2 prior comparisons
Research & development increased 15.3%
Research & development changed +15.3% from the comparable as-filed period.
$492.0M→$567.5M2 prior comparisons
Capex / revenue moved 97 bp lower
Capex / revenue changed -97 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.46%→0.49%2 prior comparisons
Receivables / revenue moved 1003 bp lower
Receivables / revenue changed -1003 basis points from the comparable as-filed period.
56.48%→46.45%2 prior comparisons
Gross margin moved 50 bp lower
Gross margin changed -50 basis points from the comparable as-filed period.
67.53%→67.02%2 prior comparisons
Total assets increased 6.0%
Total assets changed +6.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$8.2B→$8.7B4 prior comparisons
Stock-based compensation increased 4.8%
Stock-based compensation changed +4.8% from the comparable as-filed period.
$404.2M→$423.6M2 prior comparisons
Operating cash-flow margin moved 64 bp lower
Operating cash-flow margin changed -64 basis points from the comparable as-filed period.
6.54%→5.91%2 prior comparisons
Free-cash-flow margin moved 33 bp higher
Free-cash-flow margin changed +33 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
5.09%→5.42%2 prior comparisons
Operating cash flow increased 6.5%
Operating cash flow changed +6.5% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
$228.4M→$243.2M6 prior comparisons
Cash & equivalents decreased 7.1%
Cash & equivalents changed -7.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.2B→$2.1B2 prior comparisons
Research & development increased 13.2%
Research & development changed +13.2% from the comparable as-filed period.
$472.4M→$534.9M3 prior comparisons
Gross margin moved 8 bp higher
Gross margin changed +8 basis points from the comparable as-filed period.
66.53%→66.61%3 prior comparisons
Stock-based compensation increased 6.1%
Stock-based compensation changed +6.1% from the comparable as-filed period.
$379.5M→$402.5M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.